A direct-to-consumer probiotics brand, focusing on women's intimate health, has realized over $70,000 in revenue within seven months of launching on Amazon UK, selling over 6,000 units. The brand holds significant opportunities for product line expansion and entry into other markets. Housing one active Amazon Standard Identification Number (ASIN) in the Health & Personal Care category, it boasts over 300 active monthly subscriptions as of December 2024, generating a net monthly profit of $2,500. This product is notably Amazon's highest-rated vaginal probiotic, with hundreds of five-star reviews and repeat customer purchases through subscriptions. The operations are straightforward, requiring minimal weekly management due to a 100% Fulfillment by Amazon (FBA) model, facilitated by direct shipments from the UK's leading probiotics manufacturer. These probiotics, encapsulating strains like La-14 and HN001, are clinically proven and backed by scientific research. Customers are typically women with disposable income seeking feminine health solutions, and there is untapped potential within the US market and other territories. The brand includes a registered UK trademark, "Florawell," and benefits from an email list of approximately 500 buyers for future marketing endeavors. Despite limited marketing expenditure, the brand ranks well on Amazon; however, there is considerable scope for growth with improved pay-per-click (PPC) campaigns, expansion into additional channels like Shopify, and social media marketing. For potential buyers, further growth can be achieved by exploring international markets, engaging in strategic marketing, and broadening the product range. The seller, who has successfully launched and sold four other brands, is willing to offer transitional support and is open to offers from serious cash buyers.